Wordt geladen...
Novel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon?
The blood–retinal barrier (BRB) alteration is the hallmark feature of diabetic retinopathy. Vascular endothelial growth factor (VEGF) is a potent vasopermeability factor that has been implicated in the pathogenesis of BRB alteration. Inflammation also plays a crucial role in this process with involv...
Bewaard in:
| Gepubliceerd in: | Indian J Ophthalmol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Medknow Publications & Media Pvt Ltd
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4821120/ https://ncbi.nlm.nih.gov/pubmed/26953018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0301-4738.178154 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|